CARDIOVASCULAR: Eptifibatide After PCI: Brief Infusion Is Just As Good

Audio Journal of Cardiovascular Medicine, November 5th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida Eptifibatide After PCI: Brief Infusion Is Just As Good ANTHONY FUNG, University of British Columbia, Vancouver REFERENCE: Late Breaking Clinical Trials Session I, AHA 2007 Brief courses of antiplatelet therapy with the glycoprotein 2b 3a inhibitor are just as effective as longer infusions for patients receiving non-emergency percutaneous intervention. So said Anthony Fung at the first session of Late breaking Clinical Trials held at the American Heart Association's annual meeting in Orlando. He talked with Peter Goodwin about his findings.